1,2. In alignment with the Centers for Medicare & Medicaid Services’ (CMS’s) commitment to reducing health disparities and achieving health equity in CMS quality programs and within Innovation Center models, EOM is designed to advance health equity within all stages of model design, implementation and evaluation and aims to improve quality of care and equitable health outcomes for all EOM beneficiaries. Beneficiary sociodemographic factors influence health outcomes.

3,4. Disparities in cancer care based on sociodemographic status can occur throughout the cancer diagnosis and treatment trajectory, including, but not limited to, the timing of the start of treatment, stage at diagnosis, representation and access to clinical trials, shared decision making with providers, medication adherence, hospitalizations and ICU admissions near the end of life, and enrollment in hospice.

5,6,7,8. EOM participants are required to implement eight Enhanced Services as part of their participant redesign activities (PRAs). In alignment with CMS’s commitment to focusing on whole person care, EOM is designed with patient-centeredness at the forefront. To that end, one Enhanced Service required of EOM participants is gradual implementation of collecting electronic patient-reported outcomes (ePRO) for eligible EOM beneficiaries.

*Low-risk breast cancers and low-intensity prostate cancer are not included in EOM. For the purposes of EOM, low-risk breast cancer is defined as breast cancer treated with only long-term oral endocrine therapy; and low-intensity prostate cancer treated with either androgen deprivation and/or anti-androgen therapy without any other chemotherapy.